Search research articles
Contact Us
Filters
Showing results (1-10 of 99) with videos related to
Page
of 10
Sort By:
Journal of Translational Medicine
|
November 27, 2010
Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients
Chor Sang Chim
Hematology (Amsterdam, Netherlands)
|
July 9, 2019
Ficolled bone marrow is superior to bone marrow buffy coat for detection of minimal residual disease in multiple myeloma
Yinlei Bai, Chor Sang Chim
Epigenomics
|
September 30, 2015
DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma
Kwan Yeung Wong, Chor Sang Chim
Epigenomics
|
February 5, 2015
DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia
Lu Qian Wang, Chor Sang Chim
The Journal of Pharmacy and Pharmacology
|
February 18, 2020
Venetoclax, bortezomib and S63845, an MCL1 inhibitor, in multiple myeloma
Kwan Yeung Wong, Chor Sang Chim
Leukemia & Lymphoma
|
June 7, 2006
Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia
Chor-Sang Chim, Yok-Lam Kwong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2008
Pulmonary interstitial amyloidosis complicating multiple myeloma
Chor-Sang Chim, Matthew Wong, Yuenshan Fan
British Journal of Haematology
|
December 22, 2017
Molecular detection of minimal residual disease in multiple myeloma
Yinlei Bai, Alberto Orfao, Chor Sang Chim
Oncology Letters
|
November 26, 2013
Survival of >20 years in a myeloma patient with an unusual combination of t(14;16) and hyperdiploidy: A case report
Chor Sang Chim, Edmond Siu Kwan Ma
Epigenomics
|
December 1, 2011
DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family
Kwan Yeung Wong, Li Yu, Chor Sang Chim
Page
of 10
Search research articles
Search
Showing results (1-10 of 99) with videos related to
Sort By:
Page
of 10
Journal of Translational Medicine
|
November 27, 2010
Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients
Chor Sang Chim
Hematology (Amsterdam, Netherlands)
|
July 9, 2019
Ficolled bone marrow is superior to bone marrow buffy coat for detection of minimal residual disease in multiple myeloma
Yinlei Bai, Chor Sang Chim
Epigenomics
|
September 30, 2015
DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma
Kwan Yeung Wong, Chor Sang Chim
Epigenomics
|
February 5, 2015
DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia
Lu Qian Wang, Chor Sang Chim
The Journal of Pharmacy and Pharmacology
|
February 18, 2020
Venetoclax, bortezomib and S63845, an MCL1 inhibitor, in multiple myeloma
Kwan Yeung Wong, Chor Sang Chim
Leukemia & Lymphoma
|
June 7, 2006
Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia
Chor-Sang Chim, Yok-Lam Kwong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2008
Pulmonary interstitial amyloidosis complicating multiple myeloma
Chor-Sang Chim, Matthew Wong, Yuenshan Fan
British Journal of Haematology
|
December 22, 2017
Molecular detection of minimal residual disease in multiple myeloma
Yinlei Bai, Alberto Orfao, Chor Sang Chim
Oncology Letters
|
November 26, 2013
Survival of >20 years in a myeloma patient with an unusual combination of t(14;16) and hyperdiploidy: A case report
Chor Sang Chim, Edmond Siu Kwan Ma
Epigenomics
|
December 1, 2011
DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family
Kwan Yeung Wong, Li Yu, Chor Sang Chim
Page
of 10